Even though pre-albumin and Fibrinogen are all widely acknowledged to be associated with tumor prognosis, the Fibrinogen to pre-albumin ratio (FPR) has rarely been reported to evaluate the prognosis of patients with digestive tumors. Here, ALB is linked to neoplasm.